choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Namenda

Namenda Newsletter
  • Namenda (memantine) 17 Apr 2024 17:48 GMT

    … side effects of Namenda, talk with your doctor or pharmacist. … : The Food and Drug Administration (FDA) tracks side effects of … you’re having a medical emergency. Serious side effects … Namenda. This side effect wasn’t reported in clinical trials of this drug

  • Projected to Reach $8.7 Billion: Memory Enhancer Drugs Market | Tracking Trends, Innovations, Market Growth. 19 Jan 2024 17:00 GMT

    … memory-enhancer-drugs-market … Namenda ➤ Razadyne ➤ Provigill ➤ Ritalin ➤ Adderall ➤ Others ● 𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: ➤ Disease TreatmentPharmaceutical Company Ltd. ➤ Torrent Pharmaceutical, Inc. ➤ Teva Pharmaceutical

  • Biotech Industry Veterans Jeff Jonas and Al Robichaud Join Cure Ventures as Partners 08 Jan 2024 12:10 GMT

    medicines such as Mirapex, Lexapro, Vyvanse, Zulresso, Zurzuvae and Namenda … of Ionis Pharmaceuticals and chief medical officer of … , an approved drug for the treatment of bipolar depression … the success of several biotechnology companies, including Juno …

  • Delix Presents Interim Data From Phase I Trial of Novel Neuroplastogen at ACNP Annual Meeting 06 Dec 2023 13:20 GMT

    … Vyvanse, Zulresso, Zurzuvae and Namenda. In addition, across roles … potential to shift the treatment paradigm for several … of the Regenerative Medicine Division at Shire Pharmaceuticals. Earlier on … had rapid and enduring antidepressant-like effects after a …

  • As Biopharma Giants Reshape the Field, Cognition Therapeutics Sees a Place for Its Alzheimer’s Drug 23 Oct 2023 20:32 GMT

    … rate of clinical trials for AD drug candidates between … and primary care doctors and then patients all … such as Namenda® (memantine) A combination treatment combining cholinesterase … CFA, Morningstar senior strategist, biotechnology, told GEN Edge.  Biogen …

  • Say Goodbye To Alzheimer’s Disease On World Alzheimer's Day 2023, Know Causes, Symptoms, Treatments, & More 20 Sep 2023 15:27 GMT

    … to the treatment of Alzheimer's disease: Medications: Cholinesterase Inhibitors: Drugs like … 's disease. Memantine (Namenda): This medication works differently from cholinesterase inhibitors … have shown promise in clinical trials, but they may not be …

  • What Medications Are Used to Treat Alzheimer's? 21 Jun 2023 15:50 GMT

    … psychiatry in the FDA’s Center for Drug Evaluation and … medication is started as a 0.5 milligram (mg) pill … of lecanemab, reported by Yale Medicine, are: Infusion-related reactions … Diarrhea Constipation Confusion Memantine (Namenda) Memantine is an N …

  • Alzheimer’s Disease and Current Treatment 16 Jun 2023 17:24 GMT

    … process. In ongoing clinical trials, scientists are looking at … 6,11 The fourth drug, memantine (Namenda), is an N-methyl … medications have not shown meaningful patient benefit.3 The FDA … Kennelly SP, O’Neill D. Drug treatments in Alzheimer’s disease. Clin …

  • Does Medicare pay for Alzheimer’s drugs? The answer is complicated and changing 15 Jun 2023 18:29 GMT

    … know. Medicare and Alzheimer’s drugs There are no drugs or treatments to … mild to moderate disease. Namenda and Namzaric are approved for … who also have a doctor participating in a special … s. A clinical trial showed this drug slowed Alzheimer’s progression …

  • What to Expect When You Start Depression Medication 14 Jun 2023 09:51 GMT

    … best evaluation and treatment guidance will always come … which has a full FDA indication for treating several … Namenda [Read: 6 Unexpected Signs of Depression] Do Antidepressants Work … ceasing your antidepressant medications, speak with your doctor about it …

Satisfied with the content?

Continue to create your account.